secwatch.observer — SEC 8-K summary
======================================

Issuer:     Propanc Biopharma, Inc. (PPCB)
CIK:        0001517681
Form:       8-K
Filed at:   2024-06-05T23:59:59+00:00
Accession:  0001493152-24-022624
Event type: debt
Sentiment:  neutral
Materiality: 0.35
Item codes: 1.01, 2.03, 3.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Propanc Biopharma closes $49,200 convertible note financing with 15% interest, net $41,000
--------------------------------------------------------------------------------

- Entered securities purchase agreement with 1800 Diagonal Lending LLC for $49,200 convertible note; purchase price $41,000 (includes $8,200 OID).
- Note matures March 30, 2025; one-time 15% interest, total payback $56,580 due in five installments starting Nov 30, 2024.
- Upon event of default, investor may convert at 65% of lowest trading price in prior 10 days (35% discount).
- Proceeds used for general working capital; issuance exempt under Section 4(a)(2) and Rule 506 of Regulation D.
- Company has approximately 183.3 million shares of common stock outstanding as of May 22, 2024.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1517681/000149315224022624/0001493152-24-022624-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1517681/000149315224022624/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-022624

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer